Coming Soon
Find information on liver fibrosis diagnosis, including clinical documentation requirements, medical coding guidelines, and relevant healthcare resources. Learn about staging and prognosis of liver fibrosis, and explore topics such as nonalcoholic fatty liver disease NAFLD, cirrhosis, liver biopsy, FibroScan, AST ALT ratio, and ICD-10 codes for liver fibrosis. This resource provides essential information for healthcare professionals, medical coders, and patients seeking to understand liver fibrosis.
Also known as
Hepatic fibrosis
Scarring of the liver.
Alcoholic liver disease
Liver damage due to excessive alcohol use, can include fibrosis.
Other specified liver diseases
Includes various liver conditions that may cause fibrosis, if specified.
Chronic viral hepatitis
Long-term viral infections that can lead to liver fibrosis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the liver fibrosis due to alcohol?
When to use each related code
| Description |
|---|
| Liver fibrosis: Scarring of the liver. |
| Non-alcoholic fatty liver disease (NAFLD): Fat accumulation in liver. |
| Non-alcoholic steatohepatitis (NASH): Liver inflammation and damage from NAFLD. |
Coding liver fibrosis without documenting the underlying cause (e.g., alcohol, NASH) leads to inaccurate severity reflection and reimbursement.
Inconsistent staging of fibrosis (e.g., F0-F4 via biopsy, imaging) creates compliance and quality reporting issues. CDI crucial for specificity.
Failing to code related conditions like portal hypertension or esophageal varices impacts risk adjustment and resource allocation.
Patient presents with suspected liver fibrosis, potentially indicative of chronic liver disease. Presenting symptoms include fatigue, abdominal discomfort, and occasional right upper quadrant pain. Physical examination reveals mild hepatomegaly. Relevant laboratory findings demonstrate elevated liver enzymes, including AST, ALT, and GGT. Additionally, decreased albumin and prolonged prothrombin time suggest impaired liver function. Imaging studies, such as abdominal ultrasound, transient elastography, or MRI with elastography, are recommended for non-invasive assessment of liver stiffness and fibrosis staging. Patient history includes risk factors for liver fibrosis, including non-alcoholic fatty liver disease NAFLD, chronic hepatitis C, and a history of alcohol use. Differential diagnoses include cirrhosis, other chronic liver diseases, and hepatic malignancies. The initial treatment plan includes further investigation to determine the underlying etiology of liver fibrosis, management of contributing factors such as alcohol cessation or weight loss, and regular monitoring of liver function tests. Patient education regarding liver health, disease progression, and potential complications will be provided. Follow-up appointment scheduled to discuss results of imaging studies and develop a comprehensive management plan tailored to the specific etiology and stage of liver fibrosis. Medical coding will utilize ICD-10 codes for liver fibrosis, specified by etiology if known, along with codes reflecting the presenting symptoms and diagnostic procedures. Billing will reflect evaluation and management services, laboratory tests, and imaging studies.